DROMATRIX
Live / Applied — New application — assigned to an examiner (as of 27 Mar 2026)
What this means for you
Not registered yet, but its 21 Nov 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99509555
- Mark type
- Stylized text
- Filed
- 21 Nov 2025
- Attorney of record
- Todd S. Bontemps
Goods and services
- Class 005 — Pharmaceuticals: Transdermal patches featuring dronabinol for pain relief, to treat loss of appetite, severe nausea and vomiting caused by chemotherapy, to treat neuropsychiatric disorders, namely anxiety disorders, depression disorders, sleep disorders, autism spectrum disorders, seizure disorders, cognitive deficit disorders, and Tourette syndrome (TS), and to treat neurological diseases, namely, Alzheimer's disease, dementia, Parkinson's disease, Chronic traumatic encephalopathy (CTE), Multiple sclerosis (MS), epilepsy, peripheral neuropathy, migraine, and strokes
Owner
- Pike Therapeutics USA, Inc., Wilmington, DE, US
Prosecution history
- 27 Mar 2026 — ASSIGNED TO EXAMINER
- 21 Nov 2025 — APPLICATION FILING RECEIPT MAILED
- 21 Nov 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 21 Nov 2025 — NEW APPLICATION ENTERED